Pulse en una miniatura para ir a Google Books.
Cargando... The Billion Dollar Molecule: One Company's Quest for the Perfect Drugpor Barry Werth
Cargando...
Inscríbete en LibraryThing para averiguar si este libro te gustará. Actualmente no hay Conversaciones sobre este libro. Way too much nitty gritty detail for a lay reader. If you were involved in this company or a scientist you might enjoy it more than I did. ( ) Werth's book about a company's inception and its revolutionary use of rational drug design should be required reading for all in the sciences. It highlights to amazing extents the pros and cons of academia and industry, and as a current PhD student, I can fully relate to the issues. The scientific struggles of publishing and politics are all excruciatingly detailed, and you're left in awe of the immense strength and will of the characters. Werth's prose is riveting as well. I wish there were a more recent book of equal calibre, detailing maybe a company's trials in genomic medicine. A very interesting story of a pharmaceutical startup. So much hype, with no solid basis, and yet they survive. Werth does a good job explaining the business, the science, and the experience of doing the science. > Scientists, unlike, say, athletes, conjure their own competition. They seldom know precisely whom they’re competing with or where they are in the race. They hear things—rumors, reports—but the information comes at a distance and with a price: It may be exaggerated, deliberately misleading, or simply false. The atmosphere in a lab in the throes of a heated project is insular, secretive, xenophobic, superheated, and paranoid. > "There's two situations where you want to be aggressive about publishing. One is when you're behind; the other is when you're ahead. When you're ahead, you demoralize the other guy. When you're behind, you have nothing to lose. It's when you don't know that you want to be most careful." sin reseñas | añadir una reseña
Listas de sobresalientes
Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing -- atom by atom -- both a new life-saving immunosuppressant drug, and a drug to combat the virus that causes AIDS. You will be hooked from start to finish, as you go from the labs, where obsessive, fiercely competitive scientists struggle for a breakthrough, to Wall Street, where the wheeling and dealing takes on a life of its own, as Boger courts investors and finally decides to take Vertex public. Here is a fascinating no-holds-barred account of the business of science, which includes an updated epilogue about the most recent developments in the quest for a drug to cure AIDS. No se han encontrado descripciones de biblioteca. |
Debates activosNingunoCubiertas populares
Google Books — Cargando... GénerosSistema Decimal Melvil (DDC)615.19Technology Medicine and health Pharmacology and therapeutics Materia medica; Drugs; Pharmacology Pharmaceutical chemistryClasificación de la Biblioteca del CongresoValoraciónPromedio:
¿Eres tú?Conviértete en un Autor de LibraryThing. |